| 1 |
34847410 | Straightforward access to novel mitochondriotropics derived from 2-arylethanol as potent and selective antiproliferative agents. | 2022 Jan 15 |
1 |
| 2 |
35020351 | Development of 11C-Labeled ASEM Analogues for the Detection of Neuronal Nicotinic Acetylcholine Receptors (α7-nAChR). | 2022 Feb 2 |
1 |
| 3 |
33652886 | Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression. | 2021 Feb 26 |
2 |
| 4 |
33804018 | Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs. | 2021 Mar 15 |
1 |
| 5 |
34413359 | Structure activity relationships and the binding mode of quinolinone-pyrimidine hybrids as reversal agents of multidrug resistance mediated by P-gp. | 2021 Aug 19 |
1 |
| 6 |
34617531 | A multidrug-resistant P-glycoprotein assembly revealed by tariquidar-probe's super-resolution imaging. | 2021 Oct 21 |
2 |
| 7 |
31770475 | A novel fluorescence-based functional assay for human OATP1A2 and OATP1C1 identifies interaction between third-generation P-gp inhibitors and OATP1A2. | 2020 Jun |
1 |
| 8 |
32050702 | Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance. | 2020 Feb 10 |
1 |
| 9 |
30540465 | Probing the Pharmacological Binding Sites of P-Glycoprotein Using Umbrella Sampling Simulations. | 2019 May 28 |
1 |
| 10 |
29616423 | Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration. | 2018 Oct |
4 |
| 11 |
30562739 | Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity. | 2018 |
1 |
| 12 |
27178178 | Understanding the role of tariquidar, a potent Pgp inhibitor, in combination trials with cytotoxic drugs: What is missing? | 2016 Nov |
1 |
| 13 |
26496964 | Dexamethasone protects normal human liver cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand by upregulating the expression of P-glycoproteins. | 2015 Dec |
1 |
| 14 |
23593196 | Screening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interference. | 2013 |
1 |
| 15 |
22778859 | The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2). | 2011 Feb 16 |
1 |
| 16 |
20237038 | P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide. | 2010 Apr |
1 |
| 17 |
17936633 | Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives. | 2008 Jan 1 |
1 |
| 18 |
16190932 | A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine. | 2005 Oct |
1 |